Annual Shareholders Equity
$2.91 M
-$3.04 M-51.13%
December 31, 2023
Summary
- As of February 12, 2025, BBLG annual stockholders equity is $2.91 million, with the most recent change of -$3.04 million (-51.13%) on December 31, 2023.
- During the last 3 years, BBLG annual shareholders equity has risen by +$16.60 million (+121.23%).
- BBLG annual shareholders equity is now -55.80% below its all-time high of $6.58 million, reached on December 31, 2021.
Performance
BBLG Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$3.79 M
+$883.40 K+30.37%
September 30, 2024
Summary
- As of February 12, 2025, BBLG quarterly stockholders equity is $3.79 million, with the most recent change of +$883.40 thousand (+30.37%) on September 30, 2024.
- Over the past year, BBLG quarterly shareholders equity has increased by +$883.40 thousand (+30.37%).
- BBLG quarterly shareholders equity is now -42.33% below its all-time high of $6.58 million, reached on December 31, 2021.
Performance
BBLG Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
BBLG Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -51.1% | +30.4% |
| 3 y3 years | +121.2% | -33.4% |
| 5 y5 years | +133.8% | -33.4% |
BBLG Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -55.8% | at low | -42.3% | +36.8% |
| 5 y | 5-year | -55.8% | +121.2% | -42.3% | +125.1% |
| alltime | all time | -55.8% | +121.2% | -42.3% | +125.1% |
Bone Biologics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.79 M(+30.4%) |
| Jun 2024 | - | $2.91 M(-20.8%) |
| Mar 2024 | - | $3.67 M(+26.4%) |
| Dec 2023 | $2.91 M(-51.1%) | $2.91 M(-23.4%) |
| Sep 2023 | - | $3.79 M(-33.4%) |
| Jun 2023 | - | $5.69 M(+105.3%) |
| Mar 2023 | - | $2.77 M(-53.4%) |
| Dec 2022 | $5.95 M(-9.6%) | $5.95 M(+35.1%) |
| Sep 2022 | - | $4.40 M(-21.2%) |
| Jun 2022 | - | $5.59 M(-7.5%) |
| Mar 2022 | - | $6.04 M(-8.2%) |
| Dec 2021 | $6.58 M(-148.0%) | $6.58 M(-143.5%) |
| Sep 2021 | - | -$15.13 M(+3.5%) |
| Jun 2021 | - | -$14.62 M(+3.5%) |
| Mar 2021 | - | -$14.12 M(+3.2%) |
| Dec 2020 | -$13.69 M | -$13.69 M(+3.4%) |
| Sep 2020 | - | -$13.24 M(+3.1%) |
| Jun 2020 | - | -$12.84 M(+3.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | -$12.46 M(+5.0%) |
| Dec 2019 | -$11.87 M(+38.0%) | -$11.87 M(+4.3%) |
| Sep 2019 | - | -$11.38 M(+4.9%) |
| Jun 2019 | - | -$10.86 M(+8.9%) |
| Mar 2019 | - | -$9.97 M(+16.0%) |
| Dec 2018 | -$8.60 M(+2.4%) | -$8.60 M(+19.8%) |
| Sep 2018 | - | -$7.17 M(-24.1%) |
| Jun 2018 | - | -$9.46 M(+10.8%) |
| Mar 2018 | - | -$8.53 M(+1.6%) |
| Dec 2017 | -$8.40 M(+0.4%) | -$8.40 M(-23.0%) |
| Sep 2017 | - | -$10.90 M(+6.4%) |
| Jun 2017 | - | -$10.25 M(+23.9%) |
| Mar 2017 | - | -$8.27 M(-1.1%) |
| Dec 2016 | -$8.36 M(+47.2%) | -$8.36 M(+18.6%) |
| Sep 2016 | - | -$7.05 M(+32.6%) |
| Jun 2016 | - | -$5.32 M(+76.5%) |
| Mar 2016 | - | -$3.01 M(-47.0%) |
| Dec 2015 | -$5.68 M(+53.6%) | -$5.68 M |
| Dec 2014 | -$3.70 M | - |
FAQ
- What is Bone Biologics annual stockholders equity?
- What is the all time high annual shareholders equity for Bone Biologics?
- What is Bone Biologics annual shareholders equity year-on-year change?
- What is Bone Biologics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Bone Biologics?
- What is Bone Biologics quarterly shareholders equity year-on-year change?
What is Bone Biologics annual stockholders equity?
The current annual shareholders equity of BBLG is $2.91 M
What is the all time high annual shareholders equity for Bone Biologics?
Bone Biologics all-time high annual stockholders equity is $6.58 M
What is Bone Biologics annual shareholders equity year-on-year change?
Over the past year, BBLG annual stockholders equity has changed by -$3.04 M (-51.13%)
What is Bone Biologics quarterly stockholders equity?
The current quarterly shareholders equity of BBLG is $3.79 M
What is the all time high quarterly shareholders equity for Bone Biologics?
Bone Biologics all-time high quarterly stockholders equity is $6.58 M
What is Bone Biologics quarterly shareholders equity year-on-year change?
Over the past year, BBLG quarterly stockholders equity has changed by +$883.40 K (+30.37%)